Pharmacology of INS37217 [P1-(Uridine 5′)-P4- (2′-deoxycytidine 5′)tetraphosphate, Tetrasodium Salt], a Next-Generation P2Y2 Receptor Agonist for the Treatment of Cystic Fibrosis-Reference-Cited by-同舟云学术

Pharmacology of INS37217 [P1-(Uridine 5′)-P4- (2′-deoxycytidine 5′)tetraphosphate, Tetrasodium Salt], a Next-Generation P2Y2 Receptor Agonist for the Treatment of Cystic Fibrosis

Published:2002-09-01 Issue:3 Volume:302 Page:871-880
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Yerxa B. R.,Sabater J. R.,Davis C. W.,Stutts M. J.,Lang-Furr M.,Picher M.,Jones A. C.,Cowlen M.,Dougherty R.,Boyer J.,Abraham W. M.,Boucher R. C.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference32 articles.

1. Effect of extracellular ATP and UTP on fluid transport by human nasal epithelial cells in culture.

2. Human airway ion transport. Part one.

3. Regional differences in bioelectric properties and ion flow in excised canine airways.;Boucher;J Appl Physiol,1981

4. Cystic fibrosis.

5. Basal nucleotide levels, release and metabolism in normal and cystic fibrosis airways.;Donaldson;Mol Med,2000

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small-molecule drugs for cystic fibrosis: Where are we now?;Pulmonary Pharmacology & Therapeutics;2022-02

2. Role of the Purinergic P2Y2 Receptor in Pulmonary Hypertension;International Journal of Environmental Research and Public Health;2021-10-20

3. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors;British Journal of Pharmacology;2021-09-16

4. New Therapies to Correct the Cystic Fibrosis Basic Defect;International Journal of Molecular Sciences;2021-06-08

5. Purinergic receptors in airway hydration;Biochemical Pharmacology;2021-05